Rongjian Xu

Qingdao University

Papers

2

Total Citations

12

H-Index

2

About

Rongjian Xu is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung cancer treatment, with a particular focus on robot-assisted sleeve resections. His most impactful work includes the first comprehensive study on the long-term oncologic outcomes of robot-assisted bronchial single sleeve lobectomy, analyzing 104 consecutive patients with centrally located non-small cell lung cancer. This landmark 2022 study, which has garnered 9 citations, demonstrated the oncological feasibility of the approach and identified key prognostic factors for long-term survival. Xu has also innovated surgical technique through his work on single utility port robot-assisted sleeve segmentectomy for bronchial carcinoid tumors, a lung-sparing procedure particularly valuable for elderly patients. His contributions are notable for establishing evidence that robotic sleeve lobectomy can achieve outcomes comparable to traditional open surgery while offering the benefits of reduced invasiveness. Xu's research directly addresses the critical question of whether complex bronchial reconstructions can be safely performed robotically, providing surgeons with validated techniques that expand treatment options for patients with centrally located tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
The long-term oncologic outcomes of robot-assisted bronchial single sleeve lobectomy for 104 consecutive patients with centrally located non-small cell lung cancer
9 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Qingdao University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago